[go: up one dir, main page]

GB201704910D0 - High dose combi I - Google Patents

High dose combi I

Info

Publication number
GB201704910D0
GB201704910D0 GBGB1704910.7A GB201704910A GB201704910D0 GB 201704910 D0 GB201704910 D0 GB 201704910D0 GB 201704910 A GB201704910 A GB 201704910A GB 201704910 D0 GB201704910 D0 GB 201704910D0
Authority
GB
United Kingdom
Prior art keywords
combi
high dose
dose
dose combi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1704910.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LDN Pharma Ltd
Original Assignee
LDN Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LDN Pharma Ltd filed Critical LDN Pharma Ltd
Priority to GBGB1704910.7A priority Critical patent/GB201704910D0/en
Publication of GB201704910D0 publication Critical patent/GB201704910D0/en
Priority to ES18717108T priority patent/ES2897790T3/en
Priority to PCT/GB2018/050843 priority patent/WO2018178690A1/en
Priority to EP18717108.7A priority patent/EP3600433B1/en
Priority to KR1020247026962A priority patent/KR20240125082A/en
Priority to JP2020503374A priority patent/JP7657590B2/en
Priority to US16/499,230 priority patent/US20200101066A1/en
Priority to CN201880035530.6A priority patent/CN111050801B/en
Priority to CA3083850A priority patent/CA3083850A1/en
Priority to KR1020197031888A priority patent/KR20200072445A/en
Priority to AU2018244806A priority patent/AU2018244806B2/en
Priority to JP2024207994A priority patent/JP2025027084A/en
Ceased legal-status Critical Current

Links

GBGB1704910.7A 2017-03-28 2017-03-28 High dose combi I Ceased GB201704910D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1704910.7A GB201704910D0 (en) 2017-03-28 2017-03-28 High dose combi I
AU2018244806A AU2018244806B2 (en) 2017-03-28 2018-03-28 An agent that increases the expression of the Bcl2-associated agonist of cell death for the treatment of cancer
KR1020247026962A KR20240125082A (en) 2017-03-28 2018-03-28 An agent that increases the expression of the bcl2-associated agonist of cell death for the treatment of cancer
PCT/GB2018/050843 WO2018178690A1 (en) 2017-03-28 2018-03-28 An agent that increases the expression of the bcl2-associated agonist of cell death for the treatment of cancer
EP18717108.7A EP3600433B1 (en) 2017-03-28 2018-03-28 An agent that increases the expresssion of the bcl2-associated agonist of cell death for the treatment of cancer
ES18717108T ES2897790T3 (en) 2017-03-28 2018-03-28 An agent that increases expression of Bcl2-associated agonist of cell death for cancer treatment
JP2020503374A JP7657590B2 (en) 2017-03-28 2018-03-28 Agents that increase expression of BCL2-associated cell death agonists for treating cancer - Patents.com
US16/499,230 US20200101066A1 (en) 2017-03-28 2018-03-28 Agent that increases the expression of the bcl2-associated agonist of cell death for the treatment of cancer
CN201880035530.6A CN111050801B (en) 2017-03-28 2018-03-28 Agents that increase expression of BCL 2-related cell death agonists for the treatment of cancer
CA3083850A CA3083850A1 (en) 2017-03-28 2018-03-28 An agent that increases the expression of the bcl2-associated agonist of cell death for the treatment of cancer
KR1020197031888A KR20200072445A (en) 2017-03-28 2018-03-28 Agents to increase expression of BCL2-related agonists of cell death for the treatment of cancer
JP2024207994A JP2025027084A (en) 2017-03-28 2024-11-29 Agents that increase expression of BCL2-associated cell death agonists for treating cancer - Patents.com

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1704910.7A GB201704910D0 (en) 2017-03-28 2017-03-28 High dose combi I

Publications (1)

Publication Number Publication Date
GB201704910D0 true GB201704910D0 (en) 2017-05-10

Family

ID=58688039

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1704910.7A Ceased GB201704910D0 (en) 2017-03-28 2017-03-28 High dose combi I

Country Status (1)

Country Link
GB (1) GB201704910D0 (en)

Similar Documents

Publication Publication Date Title
GB201707153D0 (en) Therapy
GB201708663D0 (en) Therapy
PL3484451T3 (en) Dosage form
GB201512365D0 (en) Novel therapy
GB201719646D0 (en) Therapy
GB201615442D0 (en) Dose setting mechanism
DK3470112T3 (en) Cochlear implantat
PL3645090T3 (en) Inhaler
ZAA201800806S (en) Inhaler
GB201615439D0 (en) Dose setting mechanism
PT4066874T (en) Inhalers
GB201704911D0 (en) High dose combo I
AU201711720S (en) Inhaler
AU201810228S (en) Inhaler
GB201615455D0 (en) Last dose protection
GB201516068D0 (en) Novel therapy
FI3568181T3 (en) Inhaler
ZA202000314B (en) Inhaler
GB201505382D0 (en) Novel therapy
GB201707500D0 (en) New therapy
GB201703529D0 (en) Vaccine composition
GB201617470D0 (en) Novel therapy
GB201704910D0 (en) High dose combi I
GB201515143D0 (en) Dosimeter
GB2568502B (en) Shield

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)